These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38966016)

  • 1. OSTEOPROTEGERIN AS AN EARLY SIGN OF CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER.
    Gršković A; Ćelić T; Španjol J; Markić D; Devčić B; Bobinac D; Rački S
    Acta Clin Croat; 2023 Jul; 62(Suppl2):46-52. PubMed ID: 38966016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
    Graciolli FG; Neves KR; Barreto F; Barreto DV; Dos Reis LM; Canziani ME; Sabbagh Y; Carvalho AB; Jorgetti V; Elias RM; Schiavi S; Moysés RMA
    Kidney Int; 2017 Jun; 91(6):1436-1446. PubMed ID: 28318623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder.
    Jiang JQ; Lin S; Xu PC; Zheng ZF; Jia JY
    Nephrology (Carlton); 2011 Aug; 16(6):588-94. PubMed ID: 21649792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerostin and osteoprotegerin: new markers of chronic kidney disease mediated mineral and bone disease in children.
    Guven S; Gokce I; Cicek N; Yaman A; Vatansever P; Alpay H
    J Pediatr Endocrinol Metab; 2020 Nov; 33(11):1383-1390. PubMed ID: 33068383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
    Morena M; Jaussent I; Dupuy AM; Bargnoux AS; Kuster N; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2015 Aug; 30(8):1345-56. PubMed ID: 25854266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the ratio of serum osteoprotegerin ligand to osteoprotegerin to evaluate renal osteodystrophy in dialysis patients.
    Grzegorzewska AE; Mlot M
    Adv Perit Dial; 2005; 21():188-93. PubMed ID: 16686316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
    Doumouchtsis K; Perrea D; Doumouchtsis S; Tziamalis M; Poulakou M; Vlachos I; Kostakis A
    Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histomorphometric diagnostics of renal osteopathy in chronic dialysis patients at high risk of cardiovascular disease.
    Žamboch K; Krejčí K; Škarda J; Tichý M; Überall I; Skýpalová P; Langová K; Stejskal D; Švesták M; Zahálková J; Ščudla V; Zadražil J
    Int Urol Nephrol; 2015 Jul; 47(7):1195-201. PubMed ID: 25931273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone and Mineral Metabolism in Children with Nephropathic Cystinosis Compared with other CKD Entities.
    Ewert A; Leifheit-Nestler M; Hohenfellner K; Büscher A; Kemper MJ; Oh J; Billing H; Thumfart J; Stangl G; Baur AC; Föller M; Feger M; Weber LT; Acham-Roschitz B; Arbeiter K; Tönshoff B; Zivicnjak M; Haffner D
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32413117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum leptin in dialysis renal osteodystrophy.
    Coen G; Ballanti P; Fischer MS; Balducci A; Calabria S; Colamarco L; Di Zazzo G; Lifrieri F; Manni M; Sardella D; Nofroni I; Bonucci E
    Am J Kidney Dis; 2003 Nov; 42(5):1036-42. PubMed ID: 14582047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M
    Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of RANKL and OPG on bone mineral density in pre-dialysis chronic renal failure.
    Fahrleitner-Pammer A; Dobnig H; Dimai HP; Holzer H; Benesch T; Borchhardt K; Cejka D; Haas M
    Clin Nephrol; 2009 Jun; 71(6):652-9. PubMed ID: 19473634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients.
    Haas M; Leko-Mohr Z; Roschger P; Kletzmayr J; Schwarz C; Domenig C; Zsontsich T; Klaushofer K; Delling G; Oberbauer R
    Am J Kidney Dis; 2002 Mar; 39(3):580-6. PubMed ID: 11877577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. News on biomarkers in CKD-MBD.
    Mazzaferro S; Tartaglione L; Rotondi S; Bover J; Goldsmith D; Pasquali M
    Semin Nephrol; 2014 Nov; 34(6):598-611. PubMed ID: 25498379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Correlation of Serum Osteoprotegerin with Non-Traditional Cardiovascular Risk Factors and Arterial Stiffness in Patients with Pre-Dialysis Chronic Kidney Disease: Results from the KNOW-CKD Study.
    Chae SY; Chung W; Kim YH; Oh YK; Lee J; Choi KH; Ahn C; Kim YS
    J Korean Med Sci; 2018 Dec; 33(53):e322. PubMed ID: 30595681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
    Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
    Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of osteoprotegerin in hemodialysis patients.
    Avbersek-Luznik I; Malesic I; Rus I; Marc J
    Clin Chem Lab Med; 2002 Oct; 40(10):1019-23. PubMed ID: 12476941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum markers of bone turnover in dialyzed patients grouped by level of intact parathyroid hormone.
    Grzegorzewska AE; Mlot-Michalska M
    Adv Perit Dial; 2006; 22():203-6. PubMed ID: 16983970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Bone Histomorphometry after Kidney Transplantation.
    Keronen S; Martola L; Finne P; Burton IS; Kröger H; Honkanen E
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):894-903. PubMed ID: 31088851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.